BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Obesity
,
Breast
,
Hematopoietic cell
,
Phenobarbital
,
rs3825942
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Serine/threonine-protein kinase TOR
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Trachea
Skeletal muscle
Testes
Kidney medulla
Myometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hepatocellular dysplasia
Macrocephaly
Neurological finding
Finding related to sleep
Transplanted organ rejection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
N-acetylsphingosine
FGF19 protein, human
Congo Red
IL24 protein, human
Gramicidin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TOR1
YBX2
GGCX
ALDH7A1
NDUFC2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Smith-Kingsmore syndrome
L1000 CMAP Osteosarcoma U-2 OS cells with gene overexpression perturbations
Drug target sets for approved compounds
Chemotherapeutic treatment of MCF7, ZR-75-1, HME-CC, and ME16C cell lines
OMIM - Cortical dysplasia
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Serine/threonine-protein kinase TOR
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
mTOR and Adipose Tissue Inflammation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ